Current reports
-
Current Report No. 7/2021 — 29.01.2021 15:25
Information on transactions of a person discharging managerial responsibilities
The Management Board of Atende S.A. (“Company”, “Issuer”) informs that on 29 January 2021 it received a notification pursuant to Article 19 par. 1 of the Market Abuse Regulation (MAR)
-
Current Report No. 6/2021 — 25.01.2021 18:26
Information on transactions of a person discharging managerial responsibilities
The Management Board of Atende S.A. (“Company”, “Issuer”) informs that on 25 January 2021 it received a notification pursuant to Article 19 par. 1 of the Market Abuse Regulation (MAR)
-
Current Report No. 5/2021 — 25.01.2021 18:18
Dates of publication of periodic reports in 2021
The Management Board of Atende S.A., acting pursuant to § 80 par. 1 of the Regulation of the Minister of Finance dated 29 March 2018 on current and periodical reporting by issuers of securities and conditions
-
Current Report No. 4/2021 — 21.01.2021 18:59
Transfer of ownership of shares in Atende Medica
The Management Board of Atende S.A. (“Issuer”), further to current report No 1/2021 of 21 January 2021 on the conclusion of an agreement on the sale of shares in Atende Medica sp. z o.o. with its
-
Current Report No. 3/2021 — 21.01.2021 13:23
Disclosure of delayed confidential information about the signing of the Term Sheet concerning the potential sale of shares in a subsidiary
The Management Board of Atende S.A. (“Issuer”) hereby communicates confidential information whose publication was delayed by the Issuer on 9 December 2020: “Signing of the Term
-
Current Report No. 2/2021 — 21.01.2021 13:08
Revision of current report number 16/2020 of 21 January 2021
The Management Board of Atende S.A. publicly announces that, as a result of a clerical error in report No 16/2020 “Conclusion of an agreement on the sale of shares in Atende Medica” dated 21 January
-
Current Report No. 16/2020 (1/2021) — 21.01.2021 12:44
Conclusion of an agreement on the sale of shares in Atende Medica
The Management Board of Atende S.A. (“Issuer”, “Seller”) informs that on 21 January 2021 an agreement on the sale of shares in Atende Medica sp. z o.o. with its registered office in